论文信息 - Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan - 字舞流文

Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan

Sui‐Yuan Chang | Shan-Chwen Chang | W. Sheng | Chung-Cheng Wang | Ching-Chi Chu | Yueh-Juh Lin | Si-Man Ieong

[1] R. Balicer,et al. Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex , 2021, The New England journal of medicine.

[2] Manfred S. Green,et al. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel , 2021, The New England journal of medicine.

[3] G. Lippi,et al. Antibody response induced by the boost overdose during COVID-19 heterologous prime-boost vaccination strategy , 2021, Clinica Chimica Acta.

[4] P. Dormitzer,et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents , 2021, The New England journal of medicine.

[5] Charles Y. Tan,et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2 , 2021, Nature.

[6] P. Dormitzer,et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[7] E. Walsh,et al. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates , 2020, The New England journal of medicine.

[8] E. Walsh,et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults , 2020, Nature.

[9] I. Knezevic. Guidelines on clinical evaluation of vaccines : regulatory expectations , 2004 .